Pfizer (PFE) Stock on November 30, 2025: Institutional Buying, Metsera Deal and a 6.7% Dividend Yield
Pfizer Inc. (NYSE: PFE) is back in the spotlight as of November 30, 2025. Fresh regulatory filings show new institutional buying, analysts are nudging price targets higher, and the company has closed a multibillion‑dollar obesity deal while reshaping its post‑pandemic pipeline. This article pulls together the most relevant current Pfizer stock news as of November 30, 2025, and explains what it may mean for PFE shareholders. Key Takeaways Pfizer Stock Today: Price, Performance and Valuation Pfizer’s shares last closed at about $25.74 on November 28, 2025, according to exchange data and several market data providers. StockAnalysis Over the past 12